Citation Impact
Citing Papers
The metabolic syndrome in children and adolescents ? an IDF consensus report
2007 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Cognitive-Behavioral Therapy for Physical and Emotional Disturbances in Adolescents with Polycystic Ovary Syndrome: A Pilot Study
2008
Physiological, Pharmacological, and Nutritional Regulation of Circulating Adiponectin Concentrations in Humans
2008
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Physical Education Can Improve Insulin Resistance
2013
Approach to Adolescent Polycystic Ovary Syndrome (PCOS) in the Pediatric Endocrine Community in the USA
2005
Fetal Programming of Adrenal Androgen Excess: Lessons from a Nonhuman Primate Model of Polycystic Ovary Syndrome
2008
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Type 2 Diabetes in Children: Clinical Aspects and Risk Factors
2002
Definition of metabolic syndrome in preadolescent girls
2006
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
2012 Standout
Drospirenone/Ethinyl EstradiolVersusRosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors
2011
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
2009 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
The adrenal and polycystic ovary syndrome
2007
Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes
2004
The metabolic syndrome
2010 Standout
Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study
2010
The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance
2006
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups
2005
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Obstructive Sleep-Disordered Breathing and Fasting Insulin Levels in Nonobese Children
2005
Adipokines and Insulin Resistance
2008
Polycystic Ovary Syndrome in Adolescence
2008
Prevalence and Trends in Obesity Among US Adults, 1999-2008
2010 Standout
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
2008
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Polycystic ovarian syndrome during puberty and adolescence
2013
The metabolic syndrome
2005 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Randomized Controlled Trial Evaluating Response to Metformin Versus Standard Therapy in the Treatment of Adolescents with Polycystic Ovary Syndrome
2005
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Adiponectin – a key adipokine in the metabolic syndrome
2005
Type 2 diabetes
2017 Standout
Metformin treatment is effective in obese teenage girls with PCOS
2006
Racial differences in body fat distribution among reproductive-aged women
2009
Identification and Characterization of Metabolically Benign Obesity in Humans
2008
Congenital adrenal hyperplasia
2005
Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics
2006
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Longitudinal Study of Physiologic Insulin Resistance and Metabolic Changes of Puberty
2006
Treatment of PCOS in adolescence
2006
Is visceral obesity the cause of the metabolic syndrome?
2006
Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women
2010
Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth
2007
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome
2007
Catecholamines, Adiponectin, and Insulin Resistance as Measured by HOMA in Children with Obstructive Sleep Apnea
2010
Waist circumference, blood pressure, and lipid components of the metabolic syndrome
2006
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
2013
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?
2007
Ambulatory blood pressure monitoring in obese children: role of insulin resistance
2006
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Type 2 Diabetes in the Young
2004
Relationship Between Adiponectin and Ambulatory Blood Pressure in Obese Adolescents
2009
Contributions of -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Waist circumference is an independent predictor of insulin resistance in black and white youths
2006
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
2008
Oral Contraceptives and the Management of Hyperandrogenism–Polycystic Ovary Syndrome in Adolescents
2005
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
2009
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
The metabolic syndrome in children and adolescents
2007
Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus
2008
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators
2002
Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities
2009 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome
2006
Management of metabolic syndrome in children and adolescents
2011
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Type 2 Diabetes in the Young: The Evolving Epidemic
2004
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
2006
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus
2005 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force
2003
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society
2007
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
2010 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
2010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome
2003
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome
2003
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
2014
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Assessing Adiposity
2011
Insulin Resistance
2007
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
2012
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Interventions for preventing obesity in children
2019 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Insulin and Cancer
2003
The Metabolic Syndrome
2008 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome
2004
Childhood Obesity
2012
Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
2008
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Hepatic Insulin Clearance Is Closely Related to Metabolic Syndrome Components
2013
Impact of metformin monotherapy versus metformin with oestrogen‐progesterone on lipids in adolescent girls with polycystic ovarian syndrome
2012
Individualizing Therapies in Type 2 Diabetes Mellitus Based on Patient Characteristics: What We Know and What We Need to Know
2010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Rola Saad being referenced
Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents
2004
Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children?
2005
Insulin resistance of puberty in African-American children: lack of a compensatory increase in insulin secretion
2002
Obesity, Regional Fat Distribution, and Syndrome X in Obese BlackVersusWhite Adolescents: Race Differential in Diabetogenic and Atherogenic Risk Factors
2003
Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty?
2001
Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates
2005
Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents?
2006
Family History of Type 2 Diabetes Is Associated With Decreased Insulin Sensitivity and an Impaired Balance Between Insulin Sensitivity and Insulin Secretion in White Youth
2005
Metformin Therapy in Obese Adolescents with Polycystic Ovary Syndrome and Impaired Glucose Tolerance: Amelioration of Exaggerated Adrenal Response to Adrenocorticotropin with Reduction of Insulinemia/Insulin Resistance
2002
Hyperinsulinemia in African-American Children
2002
Adiponectin in Youth
2004
Youth Type 2 Diabetes
2005